Immunotherapy
Country
United Kingdom
Western Europe
Subject Area and Category
Immunology and Microbiology
└
Immunology
Q3
└
Immunology and Allergy
Q3
└
Oncology
Q3
Publisher
SJR 2025
0.666
Q3
SJR Score
H-Index
75
Citations / Doc (2yr)
2.06
Total Docs. (latest)
137
Total Citations (3yr)
852
Publication type
Journals
ISSN
1750743X, 17507448
Coverage
2009-2026
Journal Rank
#8,759
Subject Categories
Immunology
Q3
Immunology and Allergy
Q3
Oncology
Q3
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 137 |
| Total Docs. (3 years) | 397 |
| Total Refs. | 6,290 |
| Total Citations (3 years) | 852 |
| Citable Docs. (3 years) | 367 |
| Citations / Doc. (2 years) | 2.06 |
| Ref. / Doc. | 45.91 |
| % Female | 43.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Immunotherapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Immunotherapy has an SJR of 0.666 and is ranked Q3.
What is the SJR and quartile of Immunotherapy?
Immunotherapy has an SJR (SCImago Journal Rank) of 0.666 and its best quartile is Q3.
What is the H-index of Immunotherapy?
The H-index of Immunotherapy is 75, meaning 75 of its articles have each been cited at least 75 times.
Is Immunotherapy indexed in Scopus?
Yes. Immunotherapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.